Stockscreener 앱 받기
2.22
5.21%
0.11
시간 외 거래:
2.20
-0.02
-0.90%
전일 마감가:
$2.11
열려 있는:
$2.11
하루 거래량:
711.53K
Relative Volume:
0.13
시가총액:
$76.69M
수익:
$2.05M
순이익/손실:
$-23.15M
주가수익비율:
-0.3347
EPS:
-6.6319
순현금흐름:
$-16.93M
1주 성능:
-8.26%
1개월 성능:
-12.60%
6개월 성능:
+204.53%
1년 성능:
-38.33%
1일 변동 폭
$2.11
$2.33
1주일 범위
$2.025
$2.495
52주 변동 폭
$0.5562
$6.8908
iBio Inc Stock (IBIO) Company Profile
명칭
iBio Inc
전화
302-355-0650
주소
600 Madison Avenue, Suite 1601, New York, NY
Compare IBIO vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IBIO
iBio Inc
|
2.22 | 72.89M | 2.05M | -23.15M | -16.93M | -6.6319 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 12.04B | 3.95B | 3.34B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-21 | 개시 | Oppenheimer | Outperform |
| 2025-10-17 | 개시 | Leerink Partners | Outperform |
| 2024-05-28 | 개시 | Chardan Capital Markets | Buy |
| 2021-11-29 | 개시 | JMP Securities | Mkt Outperform |
| 2021-01-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-06-26 | 개시 | Alliance Global Partners | Buy |
모두보기
iBio Inc 주식(IBIO)의 최신 뉴스
Stock Recap: Will iBio Inc outperform its industry peersJuly 2025 Snapshot & Accurate Buy Signal Notifications - baoquankhu1.vn
IBIO: Chardan Capital Maintains 'Buy' Rating with Steady Price T - GuruFocus
IBIO: Chardan Capital Maintains 'Buy' Rating with Steady Price Target | IBIO Stock News - GuruFocus
iBio's (IBIO) Buy Rating Reiterated at Chardan Capital - MarketBeat
Can iBio Inc. stock attract ESG capital inflows2025 Fundamental Recap & Low Risk Entry Point Guides - mfd.ru
IBIO Inc (NASDAQ:IBIO) Secures $26 Million Lifeline Amid Quarterly Earnings Miss - ChartMill
iBio (IBIO) Bolsters Pipeline with $26M Financing - GuruFocus
iBio, Inc. SEC 10-Q Report - TradingView
iBio Reports Q2 Fiscal Year 2026 Financial Results and Provides Corporate Update - GlobeNewswire
IBIO stock soars 12% pre-market after company announces $26 million private placement - MSN
Fed Watch: Will iBio Inc benefit from green energy policiesMarket Growth Summary & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
iBio, Inc. (IBIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - Finviz
Forecast Cut: What is the implied volatility of Teck Resources LimitedTrade Signal Summary & Technical Confirmation Trade Alerts - baoquankhu1.vn
IBIO Stockholders Sell Shares Without Company Receiving Proceeds - GuruFocus
iBio (NASDAQ:IBIO) Stock Price Down 3.6%Here's Why - MarketBeat
What is the PEG ratio of iBio Inc.2025 EndofYear Setup & Growth Focused Investment Plans - mfd.ru
ImmunityBio Stock Rises 25.3% to $6.92 - intellectia.ai
Aug Analyst Calls: What is the PEG ratio of iBio Inc2025 Support & Resistance & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
LifeSci Capital Maintains IBio Inc(IBIO.US) With Buy Rating, Maintains Target Price $5 - 富途资讯
Will iBio Inc outperform its industry peersJuly 2025 Update & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
iBio (NYSE:IBIO) Stock Price Down 5.9%Here's What Happened - MarketBeat
Macro Review: Is iBio Inc stock positioned for long term growthDip Buying & Accurate Entry/Exit Alerts - Bộ Nội Vụ
Forecast Cut: How institutional buying supports iBio Inc. stockJuly 2025 Technicals & Daily Stock Trend Reports - Bộ Nội Vụ
iBio Announces Private Placement to Fund Pipeline Expansion - The Globe and Mail
iBio Signs Multiple Material Agreements - TradingView — Track All Markets
IBIO announces private placement financing to raise ~$26M - MSN
Key Highlights: Strategic Ratings and Milestones - timothysykes.com
iBio (NYSEMKT:IBIO) Trading 8.3% HigherHere's Why - MarketBeat
IBIO Stock Soars 12% Pre-Market After Company Announces $26 Million Private Placement - Stocktwits
LifeSci Capital Rates iBio with $5 Target Amid Antibody Advances - StocksToTrade
iBio stock jumps after $26mn private placement announcement | Tap to know more | Inshorts - Inshorts
IBio, Inc. announced that it expects to receive $26 million in funding - marketscreener.com
LifeSci Capital Boosts iBio’s Prospects with Positive Rating - timothysykes.com
IBio shares rally after $26 million private placement funding secured - MSN
iBio secures $26 million in private placement financing By Investing.com - Investing.com Nigeria
Ibio stock soars after securing $26M in private placement financing - Investing.com Nigeria
Ibio stock soars after securing $26M in private placement financing By Investing.com - Investing.com South Africa
iBio (IBIO) Secures $26M in Private Placement Financing - GuruFocus
iBio Inc. (IBIO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
iBio (IBIO) Secures $26M Financing to Advance Cardiometabolic Pr - GuruFocus
iBio secures $26 million in private placement financing - Investing.com
iBio Announces $26 Million Private Placement - manilatimes.net
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
How iBio Inc. stock performs in interest rate cyclesQuarterly Trade Summary & Expert Curated Trade Setups - ulpravda.ru
Is iBio Inc. stock supported by strong fundamentalsTrade Performance Summary & Reliable Entry Point Trade Alerts - ulpravda.ru
Will iBio Inc. stock attract ESG investorsJuly 2025 Drop Watch & AI Based Trade Execution Alerts - Улправда
iBio Inc (IBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.12%
0.87%
자본화:
|
볼륨(24시간):